Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1074 PK/RO modeling of WTX-124, a tumor-activated IL-2 prodrug, highlights the potential for a substantially improved therapeutic index compared to other IL-2 molecules
Compose a Response to This Article
Other responses
No responses have been published for this article.